Vivo Bio Tech Limited (NSE:VIVOBIOT)

Market Cap	415.19M -46.6%
Revenue (ttm)	551.03M +12.3%
Net Income	-28.58M
EPS	-1.29
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8
Open	19.01
Previous Close	19.01
Day's Range	19.01 - 19.01
52-Week Range	17.51 - 20.44
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 174
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIVOBIOT

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 9, 2026

Data Sources Report a data error